CytoSorbents, Inc. (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that it will showcase CytoSorb at the 32nd European Association for CardioThoracic Surgery Conference (EACTS) in Milan, Italy from October 18-20, 2018, and the 31st European Society of Intensive Care Medicine Congress (ESICM) in Paris, France from October 20-24, 2018.
October 18, 2018
· 6 min read